- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Obstetrics and Gynecology International
Volume 2012 (2012), Article ID 921082, 11 pages
Stem Cell Interaction with Somatic Niche May Hold the Key to Fertility Restoration in Cancer Patients
Stem Cell Biology Department, National Institute for Research in Reproductive Health, Parel, Mumbai 400 012, India
Received 6 October 2011; Revised 8 December 2011; Accepted 19 December 2011
Academic Editor: Isabelle Demeestere
Copyright © 2012 Deepa Bhartiya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The spontaneous return of fertility after bone marrow transplantation or heterotopic grafting of cryopreserved ovarian cortical tissue has surprised many, and a possible link with stem cells has been proposed. We have reviewed the available literature on ovarian stem cells in adult mammalian ovaries and presented a model that proposes that the ovary harbors two distinct populations of stem cells, namely, pluripotent, quiescent, very small embryonic-like stem cells (VSELs), and slightly larger “progenitor” ovarian germ stem cells (OGSCs). Besides compromising the somatic niche, oncotherapy destroys OGSCs since, like tumor cells, they are actively dividing; however VSELs persist since they are relatively quiescent. BMT or transplanted ovarian cortical tissue may help rejuvenate the ovarian niche, which possibly supports differentiation of persisting VSELs resulting in neo-oogenesis and follicular development responsible for successful pregnancies. Postnatal oogenesis in mammalian ovary from VSELs may be exploited for fertility restoration in cancer survivors including those who were earlier deprived of gametes and/or gonadal tissue cryopreservation options.
Stem cells hold tremendous potential and promise for regenerative medicine and have raised the hope of the public for a cure for several diseases. Reproductive biologists and infertile couples are further excited by the concept of deriving “synthetic gametes” from pluripotent stem cells, but one wonders whether generation of “synthetic gametes” is more of science fiction or a realistic option for healthy babies in the future. Hübner et al.  were the first to report spontaneous generation of oocytes enclosed within structures that resembled developing ovarian follicles by differentiation of mouse embryonic stem cells in vitro. Fetal pig skin stem cells  and rat pancreatic stem cells  cultured in vitro have also been shown to generate oocyte/follicle-like structures. Daley  summarized that the development of synthetic gametes from embryonic stem cells is fascinating basic research, but the clinical application is still a hypothetical possibility. The idea of producing gametes from induced pluripotent stem cells derived from skin fibroblasts has also been proposed . Although interesting, the major concern that would limit translation of these research efforts into clinical applications is epigenetic and genetic stability of the gametes produced . The other challenge involves establishing protocols to achieve robust and functional oocyte differentiation from embryonic stem cells, and at present this remains a highly inefficient process.
Another fast expanding area is the presence of stem cells in adult mammalian ovaries. The mammalian ovary harbors stem cells and possibly undergoes postnatal oogenesis during reproductive life rather than being endowed with a finite pool of primordial follicles at birth. Johnson et al.  provided evidence in support of postnatal oogenesis and challenged the six-decade-old paradigm by conducting simple experiments. The group demonstrated using mouse ovary the rate at which follicular atresia occurs, the ovary should be devoid of follicles by young adulthood, but this never happens. However, the idea of the ovary harboring stem cells is still not well accepted amongst reproductive biologists, and Notarianni  have recently reviewed available data in support and against the presence of stem cells in the postnatal ovary. Research in the area of germ line stem cells in mice as well as human ovaries by various groups has recently been elaborately reviewed .
One of the markers to identify stem cells is OCT-4 (Pou5f1), an octamer binding nuclear transcription factor. It is normally used to define pluripotent state of a stem cell and is well studied in embryonic (ES) and carcinoma stem cells. It is also a germline-specific maternally expressed factor . During embryonic development, OCT-4 is expressed by primordial germ cells (PGCs) and germ cells. Recently OCT-4 positive pluripotent very small embryonic-like stem cells (VSELs) have been reported in various adult somatic tissues including bone marrow and cord blood in mice as well as humans [11–13]. OCT-4 biology has indeed surprised and confused stem cell biologists due to the existence of its isoforms [14–16]. The pluripotent stem cell properties of OCT-4 are because of OCT-4A isoform localized in the nuclei as a transcription factor, whereas Oct-4B isoform is localized in the cytoplasm and has no known biological function [17, 18]. We recently reported nuclear OCT-4A positive VSELs in adult human and mice testis [19, 20]. These cells possibly undergo asymmetric cell division to give rise to slightly bigger Adark spermatogonial stem cells (SSCs), which have cytoplasmic OCT-4B. OCT-4 expression is lost as the testicular germ cells undergo further differentiation and meiosis. Similar stem cell biology also exists in the adult mammalian ovary, which will be explained in the subsequent sections. Unlike testis, OCT-4 continues to be expressed in growing follicles, since it is a maternally inherited gene but this will not be elaborated further as it is beyond the scope of this paper.
2. Stem Cells in Ovaries
Mitotically active germ cells expressing mouse VASA homolog (MVH) and synaptonemal complex protein 3 (SCP3) were reported in the adult mouse ovarian surface epithelium (OSE) by Johnson et al. . Niikura et al.  reported that aged mouse ovaries possess premeiotic germ cells that differentiate into oocytes on transfer into a young ovarian environment. Recently Zou and coworkers used MVH and FRAGILIS-based sorting method to isolate female germ line stem cells (FGSCs) from mouse ovaries [22, 23]. The MVH-sorted FGSCs of about 10–12 μm were cultured for more than 15 months and on transplantation in busulfan-treated mice resulted in live-births demonstrating postnatal oogenesis. Pacchiarotti et al.  have demonstrated the presence of FGSCs in postnatal mouse ovary using transgenic mice that express green fluorescent protein (GFP) under the control of Oct-4 promoter. They reported three different types of GFP-OCT-4 positive cells based on size—small (10–15 μm) sized cells in the ovarian surface epithelium, medium (20–30 μm) and big (50–60 μm) oocytes in the follicles. Ploidy analysis based on flow cytometry showed that 70% of these cells were tetraploid oocytes and 30% were diploid stem cells. Gong et al.  derived two pluripotent colony-forming cell lines from adult ovarian stromal cells, which also formed embryoid bodies and teratomas. They concluded that embryonic-like stem cells exist in either the ovarian stroma or the stromal cells, get reprogrammed in vitro to embryonic-like state. They have also reported that a small subgroup of the dissociated cells from adult ovary (unlike spleen and small intestine) is immunoreactive for both OCT-4 and NANOG (pluripotent marker). Reverse transcription-PCR (RT-PCR) results also demonstrate the presence of transcripts for both Oct-4 and Nanog in adult ovarian tissue.
Studies on human ovarian stem cells are relatively few in number because of scarcity of the ovarian tissue for research. Bukovsky et al.  were the first to show that scraped surface epithelium of postmenopausal human ovary develops into oocyte-like structures of about 180 μm in the presence of a medium with phenol red (estrogenic stimuli). Virant-Klun and her group [27–29] identified putative stem cells in ovarian sections and also in scraped ovarian surface epithelium (OSE) of postmenopausal women and those with premature ovarian failure. These stem cells express pluripotent transcripts Oct-4, Sox2, and Nanog, expressed cell surface antigen SSEA4, and differentiated into oocyte-like structures and parthenotes in vitro. We have recently shown the presence of VSELs in ovaries which can be easily isolated by gentle scraping of OSE in adult rabbit, sheep, monkey, and perimenopausal women. These stem cells spontaneously differentiate into oocyte-like structures and parthenotes in vitro  in agreement with published literature [28, 29, 31]. Besides VSELs with nuclear OCT-4, we have also shown slightly larger cells with cytoplasmic OCT-4, termed ovarian germ stem cells (OGSCs) similar to the terminology used by Pacchiarotti’s group. Similar to testis, VSELs with nuclear OCT-4A are relatively less in numbers in ovary as compared to the progenitors (OGSCs) with cytoplasmic OCT-4B. Similarly, two distinct populations of stem cells were also detected in adult mouse ovaries by immunolocalization and quantitative PCR (Q-PCR) analysis (Figure 1). Nuclear Oct-4A transcripts are less abundant as compared to total Oct-4 transcripts that include both A and B isoforms. Thus probably a similar pluripotent stem cell network exists in the gonads of both sexes in mice as well as humans.
The VSELs are probably the PGCs persisting into adulthood as suggested by others as well [32, 33]. Ratajczak and his group were the first to report presence of VSELs in adult body tissues and have made significant contribution in the field, which was recently compiled . It is believed that a common VSEL stem cell population exists in various body tissues, and depending on its immediate microenvironment, they differentiate into that particular lineage . VSELs are highly mobile in nature, and whenever there is any damage or disease in any part of the body, they get mobilized into circulation from the bone marrow [34–37].
At this juncture, it becomes crucial to comprehend and consolidate the various published studies so that a strong and clear concept emerges. Table 1 is a list of various publications on ovarian stem cells and our attempt to explain the results in the context of VSELs biology. As evident, there is a general agreement in the location of ovarian stem cells in the OSE.
3. Proposed Model for Oogenesis and Follicular Assembly in Adult Mammalian Ovary
Ovary harbors two distinct populations of stem cells, namely, VSELs and OGSCs (Figure 1). VSELs are quiescent stem cells whereas OGSCs are the progenitor stem cells, which proliferate, form germ cell nests, and differentiate into oocytes that get surrounded by somatic cells and assemble into primordial follicles. This model comprising two distinct stem cell populations in the gonads is in agreement with the concept put forth by Li and Clevers  in various adult body tissues like bone marrow, hair, and gut epithelium. Like the Adark SSCs in the testis, OGSCs in the ovaries also have a relatively dark nucleus after Hematoxylin and Eosin (H & E) staining. This possibly reflects simple stem cell biology in vivo wherein the open euchromatin of pluripotent VSELs possibly gets compacted, appears dark, and undergoes remodeling and reprogramming for differentiation into a particular lineage. During “nuclear reprogramming” a dramatic change in facultative heterochromatin occurs . Cells with pluripotent properties, that is, the nuclear Oct-4A positive cells, probably have abundant transcription permissive euchromatin, which becomes compacted due to stable association of histones with the chromatin in Adark SSCs in testis and OGSCs in ovary, similar to that reported during ES cell differentiation . Thus, because of intense “nuclear reprogramming” the early progenitor cells, namely, OGSCs and Adark SSCs appear dark.
During three-week culture of the scraped OSE cells, the stem cells give rise to oocyte-like structures whereas the epithelial cells undergo epithelial-mesenchymal transition (EMT) to give rise to somatic granulosa-like cells . The granulosa-like cells surround the developing oocyte resulting in follicular assembly in vitro. The differentiating oocyte undergoes meiosis and exhibits various germ cell markers, formation of Balbiani body-like structures, and characteristic cytoplasmic streaming in vitro (unpublished data). Similar views have been recently put forth by other groups as well [41, 42]. Bukovsky and group have proposed that possibly this EMT in vivo occurs in the tunica albuginea region of the ovary and may be involved in primordial follicle assembly. Figure 2 is a diagrammatic representation of the proposed model for postnatal oogenesis and follicular assembly from ovarian stem cells.
4. Stem Cells, Somatic Niche, and Menopause
Menopause implies exhausted ovarian follicle reserve and may be age related or induced prematurely by gonadotoxic insults including oncotherapy in the case of cancer survivors. But several groups have shown the presence of stem cells in the OSE of postmenopausal ovary [27–30] and in aged mouse ovary . Why are these stem cells unable to differentiate and replenish the follicular pool? Why does menopause occur? The emerging literature supports the concept that it is most likely a compromised somatic niche (a cellular and molecular microenvironment that regulates stem cell function) that is unable to support stem cell differentiation [41, 43, 44] that causes menopause. Niikura et al.  demonstrated that stem cells exist in aged ovary, which is otherwise devoid of any oocytes. To demonstrate that the stem cells still retain the differentiation potential, they performed ovarian transplantation studies. Grafting of aged ovarian tissue of Oct4-GFP transgenic mice onto wild type young mouse ovary resulted in follicles containing GFP positive oocytes. In contrast, exposure of young ovarian tissue to aged environment resulted in reduced number of immature follicles. They proposed that failure of oocyte replenishment in the aged ovary was probably due to impairment of the somatic microenvironment rather than depletion/aging of the stem cells. In a similar study performed previously in male mice, SSC transplantation in irradiated testis was only able to support colonization and not differentiation. This has lead to a similar conclusion that the compromised somatic niche does not support stem cell differentiation .
We studied the presence of VSELs and OGSCs in chemo-sterilized mouse ovaries. We have observed that the quiescent VSELs persist and are resistant to therapy whereas the rapidly dividing OGSCs and mature follicles are lost resulting in premature ovarian failure (unpublished results). Similar resistance of VSELs has recently been demonstrated in mouse bone marrow after whole body irradiation .
It becomes pertinent to refer to two published studies here. Firstly Lee et al.  could rescue chemotherapy-induced premature ovarian failure in a mouse model by bone marrow (BM) transplantation. They were however intrigued by the fact that all the pregnancies were of recipient origin and not of donor BM. Their results can be explained, if we consider that the autologous VSELs that survived chemotherapy (because of their quiescent nature) underwent differentiation, folliculogenesis, and pregnancy in response to some signal provided by the transplanted BM. Secondly Fu et al.  transplanted bone-marrow-derived mesenchymal stem cells (MSCs) in ovaries of chemotherapy-induced ovarian damage and reported improved ovarian function. They showed that the MSCs secreted cytokines and inhibited chemotherapy-induced apoptosis of granulosa cells. They concluded that transplanted MSCs play an important role in ovarian microenvironment and protect ovary from chemotherapy-induced damage through secretion of cytoprotective proteins.
5. Clinical Evidence for Spontaneous Restoration of Fertility
The current available options offered to female cancer patients for fertility preservation include gonadal shielding, cryopreservation of egg/embryo, and/or ovarian cortical tissue prior to oncotherapy. The eggs or embryos are utilized to achieve parenthood by standard assisted reproductive techniques when required whereas the cryopreserved ovarian tissue fragments are transplanted at either orthotopic or heterotopic site to serve as a source of gametes . To date thirteen pregnancies have been reported after orthotopic transplantation of ovarian cortical tissue on the surface of the atrophied ovary . Interestingly, after heterotopic transplantation of cryopreserved ovarian cortical tissue or after allogeneic bone marrow transplantation, spontaneous recovery of intact, atrophied, and menopausal ovary has been reported resulting in spontaneous pregnancies [51–55]. Similarly a study has shown that bone marrow transplantation (BMT) in aged mice also helps sustain ovarian function .
Fertility restoration in these cases could be because of (i) restoration of lost germ stem cells or (ii) improved functionality of compromised niche in the atrophied ovary that is now able to support oogenesis and follicular assembly. Veitia et al.  provided evidence that spontaneous fertility after oncotherapy or allogeneic bone marrow transplantation was not because of donor bone-marrow-derived germline stem cells, as microsatellite analysis showed that the baby was of recipient origin. Thus it is becoming clear that the BMT or transplanted tissue somehow provides the necessary endocrine/paracrine signals to the compromised niche (rather than being a source of oocytes) and helps in restoration of ovarian function. The stem cell connection with spontaneous restoration of fertility has already been suggested by Oktay .
Research efforts must be intensified to identify the actual factors that are essential to restore functionality of the gonadal niche. Similar regenerative signals exist in young and aged male blood  which can also rejuvenate follicular dynamics in an aged ovary. Sönmezer et al.  have thrown open a discussion that low levels of androgens may have a role in the regenerative effect reported by Niikura et al. . To support their view they gave the example of polycystic ovarian syndrome, where mildly increased androgens may be responsible for higher than average number of follicles observed and delayed menopause. Whether it is a reflection of increased stem cell activity needs to be demonstrated! Secondly treatment with dehydroepiandrosterone (a mild androgen) has been shown to improve ovarian response to fertility drugs .
This paper consolidates the published literature and discusses it in the context of the existence of two distinct stem cell populations in the ovary in an effort to bring more clarity in the field of adult mammalian oogenesis. It also discusses the possibility of restoring fertility by reconstructing the ovarian somatic niche. If true, various epigenetic and genetic concerns associated with long-term culture and differentiation of embryonic stem cells to make “synthetic gametes” or in vitro culture of OSE to generate autologous oocytes or maturation of primordial follicles in vitro may be overcome. This approach will open up new and novel, non-invasive avenues for fertility restoration, offer new means to treat female infertility, and delay menopause. Moreover, even patients who were deprived of fertility preservation options prior to oncotherapy stand to benefit by advances in this field.
|BMT:||Bone marrow transplantation|
|EMT:||Epithelial mesenchymal transition|
|ES:||Embryonic stem cells|
|FGSCs:||Female germline stem cells|
|GFP:||Green fluorescent protein|
|H & E:||Hematoxylin & eosin staining|
|LRCs:||Label retaining cells|
|MSC:||Mesenchymal stem cells|
|MVH:||Mouse VASA homolog|
|Oct-4:||Octamer binding protein 4|
|OGSC:||Ovarian germ stem cells|
|OSE:||Ovarian surface epithelium|
|PGC:||Primordial germ cells|
|Q-PCR:||Quantitative polymerase chain reaction|
|RT-PCR:||Reverse transcription polymerase chain reaction|
|SSCs:||Spermatogonial stem cells|
|VSELs:||Very small embryonic-like stem cells.|
Key Messages(i)Two distinct populations of stem cells exist in mammalian gonads including nuclear OCT-4 positive very small embryonic like stem cells (VSELs) and progenitor stem cells with cytoplasmic OCT-4 that is, Adark spermatogonial stem cells (SSCs) in testis and ovarian germ stem cells (OGSCs) in ovary.(ii)VSELs are relatively quiescent in nature and possibly undergo asymmetric cell division to give rise to progenitor stem cells which divide rapidly and maintain tissue homeostasis. The progenitor stem cells further differentiate and undergo meiosis to give rise to haploid gametes.(iii)Oncotherapy being nonspecific by nature targets all rapidly dividing tissues in the body in addition to tumor cells. It destroys the progenitor stem cells in the gonads and also the haploid gametes, resulting in azoospermia in men and premature ovarian failure and menopause in women. Since the somatic microenvironment is compromised, it is unable to support differentiation of the persisting VSELs into functional gametes.(iv)The existing challenge is to restore the somatic niche, thereby facilitating the differentiation of resident/ persisting VSELs to form functional gametes leading to fertility restoration. Preliminary clinical evidence of spontaneous pregnancies after heterotopic transplantation of ovarian cortical tissue or allogeneic bone marrow transplantation lends support to this concept.
The authors acknowledge wholeheartedly the contributions of their colleagues for their valuable research in the field of ovarian stem cells including those authors whom they may have inadvertently not mentioned. They sincerely thank Dr. Astrid Lobo Gajiwala at Tata Memorial Hospital, Mumbai, India, for critical review of the paper.
- K. Hübner, G. Fuhrmann, L. K. Christenson et al., “Derivation of oocytes from mouse embryonic stem cells,” Science, vol. 300, no. 5623, pp. 1251–1256, 2003.
- P. W. Dyce, L. Wen, and J. Li, “In vitro germline potential of stem cells derived from fetal porcine skin,” Nature Cell Biology, vol. 8, no. 4, pp. 384–390, 2006.
- S. Danner, J. Kajahn, C. Geismann, E. Klink, and C. Kruse, “Derivation of oocyte-like cells from a clonal pancreatic stem cell line,” Molecular Human Reproduction, vol. 13, no. 1, pp. 11–20, 2007.
- G. Q. Daley, “Gametes from embryonic stem cells: a cup half empty or half full?” Science, vol. 316, no. 5823, pp. 409–410, 2007.
- A. T. Clark, B. T. Phillips, and K. E. Orwig, “Male fertility in the test tube,” Nature Medicine, vol. 17, no. 12, pp. 1564–1565, 2011.
- A. I. Marques-Mari, O. Lacham-Kaplan, J. V. Medrano, A. Pellicer, and C. Simón, “Differentiation of germ cells and gametes from stem cells,” Human Reproduction Update, vol. 15, no. 3, pp. 379–390, 2009.
- J. Johnson, J. Canning, T. Kaneko, J. K. Pru, and J. L. Tilly, “Germline stem cells and follicular renewal in the postnatal mammalian ovary,” Nature, vol. 428, no. 6979, pp. 145–150, 2004.
- E. Notarianni, “Reinterpretation of evidence advanced for neo-oogenesis in mammals, in terms of a finite oocyte reserve,” Journal of Ovarian Research, vol. 4, no. 1, article 1, 2011.
- I. Virant-Klun, M. Stimpfel, and T. Skutella, “Ovarian pluripotent/multipotent stem cells and in vitro oogenesis in mammals,” Histology and Histopathology, vol. 26, no. 8, pp. 1071–1082, 2011.
- H. R. Scholer, S. Ruppert, N. Suzuki, K. Chowdhury, and P. Gruss, “New type of POU domain in germ line-specific protein Oct-4,” Nature, vol. 344, no. 6265, pp. 435–439, 1990.
- D. Bhartiya, A. Shaikh, P. Nagvenkar, et al., “Very small embryonic-like stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous stem cell therapy,” Stem Cells and Development, vol. 21, no. 1, pp. 1–6, 2012.
- E. K. Zuba-Surma, M. Kucia, A. Abdel-Latif et al., “Morphological characterization of very small embryonic-like stem cells (VSELs) by ImageStream system analysis,” Journal of Cellular and Molecular Medicine, vol. 12, no. 1, pp. 292–303, 2008.
- M. Kucia, M. Halasa, M. Wysoczynski et al., “Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood—preliminary report,” Leukemia, vol. 21, no. 2, pp. 297–303, 2007.
- S. Liedtke, J. Enczmann, S. Waclawczyk, P. Wernet, and G. Kögler, “Oct4 and Its Pseudogenes Confuse Stem Cell Research,” Cell Stem Cell, vol. 1, no. 4, pp. 364–366, 2007.
- S. Liedtke, M. Stephan, and G. Kögler, “Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research,” Biological Chemistry, vol. 389, no. 7, pp. 845–850, 2008.
- X. Wang and J. Dai, “Isoforms of Oct4 contribute to the confusing diversity in stem cell biology,” Stem Cells, vol. 28, no. 5, pp. 885–893, 2010.
- G. Cauffman, I. Liebaers, A. van Steirteghem, and H. van de Velde, “POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos,” Stem Cells, vol. 24, no. 12, pp. 2685–2691, 2006.
- J. Lee, H. K. Kim, J. Y. Rho, Y. M. Han, and J. Kim, “The human OCT-4 isoforms differ in their ability to confer self-renewal,” Journal of Biological Chemistry, vol. 281, no. 44, pp. 33554–33565, 2006.
- D. Bhartiya, S. Kasiviswanathan, and A. Shaikh, “Cellular origin of testis derived pluripotent stem cells: a case for very small embryonic-like stem cells (VSELs),” Stem Cells and Development, vol. 21, no. 5, pp. 670–674, 2012.
- D. Bhartiya, S. Kasiviswanathan, S. K. Unni et al., “Newer insights into premeiotic development of germ cells in adult human testis using Oct-4 as a stem cell marker,” Journal of Histochemistry and Cytochemistry, vol. 58, no. 12, pp. 1093–1106, 2010.
- Y. Niikura, T. Niikura, and J. L. Tilly, “Aged mouse ovaries possess rare premeiotic germ cells that can generate oocytes following transplantation into a young host environment,” Aging, vol. 1, no. 12, pp. 971–978, 2009.
- K. Zou, Z. Yuan, Z. Yang et al., “Production of offspring from a germline stem cell line derived from neonatal ovaries,” Nature Cell Biology, vol. 11, no. 5, pp. 631–636, 2009.
- K. Zou, L. Hou, K. Sun, W. Xie, and J. Wu, “Improved efficiency of female germline stem cell purification using fragilis-based magnetic bead sorting,” Stem Cells and Development, vol. 20, no. 12, pp. 2197–2204, 2011.
- J. Pacchiarotti, C. Maki, T. Ramos et al., “Differentiation potential of germ line stem cells derived from the postnatal mouse ovary,” Differentiation, vol. 79, no. 3, pp. 159–170, 2010.
- S. P. Gong, S. T. Lee, E. J. Lee et al., “Embryonic stem cell-like cells established by culture of adult ovarian cells in mice,” Fertility and Sterility, vol. 93, no. 8, pp. 2594–2601, 2010.
- A. Bukovsky, M. Svetlikova, and M. R. Caudle, “Oogenesis in cultures derived from adult human ovaries,” Reproductive Biology and Endocrinology, vol. 3, article 17, 2005.
- I. Virant-Klun, N. Zech, P. Rozman et al., “Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes,” Differentiation, vol. 76, no. 8, pp. 843–856, 2008.
- I. Virant-Klun, P. Rozman, B. Cvjeticanin et al., “Parthenogenetic embryo-like structures in the human ovarian surface epithelium cell culture in postmenopausal women with no naturally present follicles and oocytes,” Stem Cells and Development, vol. 18, no. 1, pp. 137–149, 2009.
- I. Virant-Klun and T. Skutella, “Stem cells in aged mammalian ovaries,” Aging, vol. 2, no. 1, pp. 3–6, 2010.
- S. Parte, D. Bhartiya, J. Telang et al., “Detection, characterization, and spontaneous differentiation in vitro of very small embryonic-like putative stem cells in adult mammalian ovary,” Stem Cells and Development, vol. 20, no. 8, pp. 1451–1464, 2011.
- A. Bukovsky, M. R. Caudle, I. Virant-Klun et al., “Oogenesis in adult humans and totipotency of adult ovarian stem cells,” Birth Defects Research Part C, vol. 87, no. 1, pp. 64–89, 2009.
- M. de Felici, “Germ stem cells in the mammalian adult ovary: considerations by a fan of the primordial germ cells,” Molecular Human Reproduction, vol. 16, no. 9, pp. 632–636, 2010.
- M. Z. Ratajczak, R. Liu, W. Marlicz et al., “Identification of very small embryonic/epiblast-like stem cells (VSELs) circulating in peripheral blood during organ/tissue injuries,” Methods in Cell Biology, vol. 103, pp. 31–54, 2011.
- A. Abdel-Latif, E. K. Zuba-Surma, K. M. Ziada et al., “Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia,” Experimental Hematology, vol. 38, no. 12, pp. 1131–1142, 2010.
- E. Paczkowska, M. Kucia, D. Koziarska et al., “Clinical evidence that very small embryonic-like stem cells are mobilized into peripheral blood in patients after stroke,” Stroke, vol. 40, no. 4, pp. 1237–1244, 2009.
- E. K. Zuba-Surma, M. Kucia, B. Dawn, Y. Guo, M. Z. Ratajczak, and R. Bolli, “Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 44, no. 5, pp. 865–873, 2008.
- M. J. Kucia, M. Wysoczynski, W. Wu, E. K. Zuba-Surma, J. Ratajczak, and M. Z. Ratajczak, “Evidence that very small embryonic-like stem cells are mobilized into peripheral blood,” Stem Cells, vol. 26, no. 8, pp. 2083–2092, 2008.
- L. Li and H. Clevers, “Coexistence of quiescent and active adult stem cells in mammals,” Science, vol. 327, no. 5965, pp. 542–545, 2010.
- K. Sha and L. A. Boyer, “The chromatin signature of pluripotent cells,” in Stem Book, Harvard Stem Cell Institute, Cambridge, Mass, USA, 2009.
- D. Phanstiel, J. Brumbaugh, T. Berggren et al., “Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 11, pp. 4093–4098, 2008.
- A. Bukovsky, “Ovarian stem cell niche and follicular renewal in mammals,” Anatomical Record, vol. 294, no. 8, pp. 1284–1306, 2011.
- Y. Zhu, M. Nilsson, and K. Sundfeldt, “Phenotypic plasticity of the ovarian surface epithelium: TGF-β1 induction of Epithelial to Mesenchymal Transition (EMT) in vitro,” Endocrinology, vol. 151, no. 11, pp. 5497–5505, 2010.
- J. L. Tilly and E. E. Telfer, “Purification of germline stem cells from adult mammalian ovaries: a step closer towards control of the female biological clock?” Molecular Human Reproduction, vol. 15, no. 7, pp. 393–398, 2009.
- E. Massasa, X. S. Costa, and H. S. Taylor, “Failure of the stem cell niche rather than loss of oocyte stem cells in the aging ovary,” Aging, vol. 2, no. 1, pp. 1–2, 2010.
- Z. Zhang, S. Shao, and M. L. Meistrich, “The radiation-induced block in spermatogonial differentiation is due to damage to the somatic environment, not the germ cells,” Journal of Cellular Physiology, vol. 211, no. 1, pp. 149–158, 2007.
- J. Ratajczak, M. Wysoczynski, E. Zuba-Surma et al., “Adult murine bone marrow-derived very small embryonic-like stem cells differentiate into the hematopoietic lineage after coculture over OP9 stromal cells,” Experimental Hematology, vol. 39, no. 2, pp. 225–237, 2011.
- H.-J. Lee, K. Selesniemi, Y. Niikura et al., “Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure,” Journal of Clinical Oncology, vol. 25, no. 22, pp. 3198–3204, 2007.
- X. Fu, Y. He, C. Xie, and W. Liu, “Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage,” Cytotherapy, vol. 10, no. 4, pp. 353–363, 2008.
- I. Demeestere, P. Simon, S. Emiliani, A. Delbaere, and Y. Englert, “Orthotopic and heterotopic ovarian tissue transplantation,” Human Reproduction Update, vol. 15, no. 6, pp. 649–665, 2009.
- J. Donnez, S. Silber, C. Y. Andersen et al., “Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births,” Annals of Medicine, vol. 43, no. 6, pp. 437–450, 2011.
- K. Oktay, I. Türkçüoğlu, and K. A. Rodriguez-Wallberg, “Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: what is the explanation?” Fertility and Sterility, vol. 95, no. 2, pp. 804.e7–804.e10, 2011.
- K. Oktay, S. Goswami, and Z. Darzynkiewicz, “Manipulating ovarian aging: a new frontier in fertility preservation,” Aging, vol. 3, no. 1, pp. 19–21, 2011.
- I. Demeestere, P. Simon, F. Buxant et al., “Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report,” Human Reproduction, vol. 21, no. 8, pp. 2010–2014, 2006.
- A. D. Schimmer, M. Quatermain, K. Imrie et al., “Ovarian function after autologous bone marrow transplantation,” Journal of Clinical Oncology, vol. 16, no. 7, pp. 2359–2363, 1998.
- N. Salooja, R. M. Szydlo, G. Socie et al., “Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey,” Lancet, vol. 358, no. 9278, pp. 271–276, 2001.
- K. Selesniemi, H.-J. Lee, T. Niikura, and J. L. Tilly, “Young adult donor bone marrow infusions into female mice postpone age-related reproductive failure and improve offspring survival,” Aging, vol. 1, no. 1, pp. 49–57, 2009.
- R. A. Veitia, E. Gluckman, M. Fellous, and J. Soulier, “Recovery of female fertility after chemotherapy, irradiation, and bone marrow allograft: further evidence against massive oocyte regeneration by bone marrow-derived germline stem cells,” Stem Cells, vol. 25, no. 5, pp. 1334–1335, 2007.
- K. Oktay, “Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline stem cell connection?” Human Reproduction, vol. 21, no. 6, pp. 1345–1348, 2006.
- Y. Niikura, T. Niikura, N. Wang, C. Satirapod, and J. L. Tilly, “Systemic signals in aged males exert potent rejuvenating effects on the ovarian follicle reserve in mammalian females,” Aging, vol. 2, no. 12, pp. 999–1003, 2010.
- M. Sönmezer, A. P. Cil, and K. Oktay, “Ongoing pregnancies from early retrieval of prematurely developing antral follicles after DHEA supplementation,” Reproductive Biomedicine Online, vol. 19, no. 6, pp. 816–819, 2009.
- A. Bukovský, J. A. Keenan, M. R. Caudle, J. Wimalasena, N. B. Upadhyaya, and S. E. Van Meter, “Immunohistochemical studies of the adult human ovary: possible contribution of immune and epithelial factors to folliculogenesis,” American Journal of Reproductive Immunology, vol. 33, no. 4, pp. 323–340, 1995.
- A. Bukovsky, M. R. Caudle, M. Svetlikova, and N. B. Upadhyaya, “Origin of germ cells and formation of new primary follicles in adult human ovaries,” Reproductive Biology and Endocrinology, vol. 2, article 20, 2004.
- J. Johnson, J. Bagley, M. Skaznik-Wikiel et al., “Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood,” Cell, vol. 122, no. 2, pp. 303–315, 2005.
- A. Bukovsky, M. E. Ayala, R. Dominguez, M. Svetlikova, and R. Selleck-White, “Bone marrow derived cells and alternative pathways of oogenesis in adult rodents,” Cell Cycle, vol. 6, no. 18, pp. 2306–2309, 2007.
- P. P. Szotek, H. L. Chang, K. Brennand et al., “Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 34, pp. 12469–12473, 2008.
- D. Zhang, H. Fouad, W. D. Zoma, S. A. Salama, M. J. Wentz, and A. Al-Hendy, “Expression of stem and germ cell markers within nonfollicle structures in adult mouse ovary,” Reproductive Sciences, vol. 15, no. 2, pp. 139–146, 2008.
- R. A. Anderson, N. Fulton, G. Cowan, S. Coutts, and P. T. Saunders, “Conserved and divergent patterns of expression of DAZL, VASA and OCT4 in the germ cells of the human fetal ovary and testis,” BMC Developmental Biology, vol. 7, article 136, 2007.